Purpose: To determine whether integration of data on body composition and radiomic features obtained using baseline 18 F-FDG positron emission tomography/computed tomography (PET/CT) images can be used to predict the prognosis of patients with stage IV non-small cell lung cancer (NSCLC).
Methods: A total of 107 patients with stage IV NSCLC were retrospectively enrolled in this study. We used the 3D Slicer (The National Institutes of Health, Bethesda, Maryland) software to extract the features of PET and CT images.
Objective: To explore a prediction model for lymphovascular invasion (LVI) on cTNM radiologic solid non-small cell lung cancer (NSCLC) based on a 2-deoxy-2[F]fluoro-D-glucose ([F]F-FDG) positron emission tomography-computed tomography (PET-CT) radiomics analysis.
Methods: The present work retrospectively included 148 patients receiving surgical resection and verified pathologically with cTNM radiologic solid NSCLC. The cases were randomized into training or validation sets in the ratio of 7:3.
Background: Treatment of radiotherapy (RT) combined with immune checkpoint inhibitor (ICI) may remarkably improve the prognosis in patients with metastatic non-small cell lung cancer (NSCLC). However, the treatment time of RT, irradiated lesion and the optimum combined scheme, have not been fully determined.
Methods: Data regarding overall survival (OS), progression-free survival (PFS), treatment response, and adverse events of 357 patients with advanced NSCLC treated with ICI alone or in combination with RT prior to/during ICI treatment were retrospectively collected.
Objective: To establish F-FDG PET/CT radiomics model for predicting brain metastasis in non-small cell lung cancer (NSCLC) patients.
Methods: This research comprised 203 NSCLC patients who had received surgical therapy at two institutions. To identify independent predictive factors of brain metastasis, metabolic indicators, CT features, and clinical features were investigated.
Rationale And Objectives: To explore the correlation between the tumor dissemination characteristic at F-fluoro-deoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT) images and the outcome of first-line systemic therapy for stage IV non-small cell lung cancer (NSCLC).
Materials And Methods: The current retrospective study included 101 NSCLC patients receiving first-line systemic therapy with baseline F-FDG PET/CT images available. The distance between the two lesions that were the farthest apart was defined as D to calculate the tumor dissemination.